Trials / Completed
CompletedNCT00423007
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With a History of Allergic Conjunctivitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (planned)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment in subjects with a history of allergic conjunctivitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromfenac | |
| DRUG | Placebo |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2007-01-17
- Last updated
- 2013-03-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00423007. Inclusion in this directory is not an endorsement.